CCM
Coldstream Capital Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.05M | Buy |
37,673
+6,811
| +22% | +$732K | 0.07% | 164 |
|
|
2025
Q1 | $3.11M | Buy |
30,862
+1,230
| +4% | +$124K | 0.07% | 168 |
|
|
2024
Q4 | $2.65M | Buy |
29,632
+2,306
| +8% | +$206K | 0.06% | 194 |
|
|
2024
Q3 | $2.3M | Buy |
27,326
+2,346
| +9% | +$198K | 0.05% | 211 |
|
|
2024
Q2 | $1.92M | Buy |
24,980
+7,431
| +42% | +$572K | 0.05% | 214 |
|
|
2024
Q1 | $1.2M | Buy |
17,549
+37
| +0.2% | +$2.53K | 0.03% | 290 |
|
|
2023
Q4 | $1.01M | Buy |
17,512
+713
| +4% | +$41.2K | 0.03% | 293 |
|
|
2023
Q3 | $887K | Sell |
16,799
-412
| -2% | -$21.8K | 0.03% | 280 |
|
|
2023
Q2 | $931K | Buy |
17,211
+279
| +2% | +$15.1K | 0.03% | 283 |
|
|
2023
Q1 | $847K | Buy |
16,932
+1,072
| +7% | +$53.6K | 0.03% | 298 |
|
|
2022
Q4 | $734K | Buy |
+15,860
| New | +$734K | 0.03% | 318 |
|
|
2022
Q2 | $481K | Buy |
12,901
+1,123
| +10% | +$41.9K | 0.02% | 404 |
|
|
2022
Q1 | $522K | Sell |
11,778
-213
| -2% | -$9.44K | 0.02% | 365 |
|
|
2021
Q4 | $509K | Buy |
11,991
+5,687
| +90% | +$241K | 0.02% | 420 |
|
|
2021
Q3 | $241K | Buy |
6,304
+496
| +9% | +$19K | 0.01% | 348 |
|
|
2021
Q2 | $248K | Buy |
+5,808
| New | +$248K | 0.01% | 443 |
|
|
2021
Q1 | – | Sell |
-6,027
| Closed | -$217K | – | 442 |
|
|
2020
Q4 | $217K | Buy |
+6,027
| New | +$217K | 0.01% | 371 |
|
|
2020
Q1 | – | Sell |
-5,096
| Closed | -$231K | – | 290 |
|
|
2019
Q4 | $231K | Buy |
+5,096
| New | +$231K | 0.02% | 302 |
|
|
2019
Q3 | – | Sell |
-4,914
| Closed | -$211K | – | 335 |
|
|
2019
Q2 | $211K | Buy |
+4,914
| New | +$211K | 0.02% | 301 |
|